RxDoctor Payments DataLook up a doctor →

Tamer Alsebai, MD

Rheumatology · Little Rock, ARNPI 1528091071

Payments from drug & device makers

$5,560in general payments, 2019–2025

Across 306 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$1K
  • GSK$548
  • Pfizer$353
  • E.r. Squibb & Sons, L.L.C.$272
  • Boehringer Ingelheim$260
  • plus $1K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,560 in reported general payments places this provider in the 50th percentile of 48 rheumatology providers in Arkansas.

See all rheumatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$3,061,742
Medicare patients
666
Services billed
182,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →